AMJEVITA FDA approval date

The FDA approved AMJEVITA on 23 Sep 2016.

FDA approval date
23 Sep 2016

Drug identity has not yet been verified against registry records

Also recorded as ADALIMUMAB-ATTO

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-09-23DayAMJEVITAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761024", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["AMJEVITA"], "active_ingredients": ["ADALIMUMAB-ATTO"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160923", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026